Eneboparatide for treating chronic hypoparathyroidism [ID6532]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Satralizumab for treating thyroid eye disease [ID6648]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Teprotumumab for treating thyroid eye disease [ID6432]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Veligrotug for treating thyroid eye disease [ID6636]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC